ScriptSwitch provides an innovative prescribing software product to Primary Care Trusts, which is then employed by GPs in their surgeries. The software delivers consistency and conformity in prescribing, whilst quantifying and reporting on cost savings.

ISIS invested funds from the Baronsmead VCTs in a £9.9m Equity Release transaction alongside previous funders Midven, a regional Midlands Fund Manager.

'We have been very impressed with ISIS's knowledge and understanding of both the Primary Care and IT Healthcare markets.' Mike Washburn, Managing Director.

Timeline:

- 2007  ISIS invests in ScriptSwitch

- 2009 ScriptSwitch sold to UnitedHealth UK